Yüklüyor......
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is an aggressive subtype of the disease with poor clinical outcomes and limited therapeutic options. Immune checkpoint blockade (CP) has surged to the forefront of cancer therapies with widespread clinical success in a variety of cancer types. However, the percen...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8124136/ https://ncbi.nlm.nih.gov/pubmed/34063642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22094843 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|